An Observational, Prospective Cohort Study to Evaluate Safety and Efficacy of RemsimaTM in Patients with Rheumatoid Arthritis First published 11/02/2015 Last updated 15/02/2019 EU PAS number:EUPAS8571 Study Ongoing
KyungMin Baek postmarket_safetyreport@celltrion.comStudy contactpostmarket_safetyreport@celltrion.com